152 related articles for article (PubMed ID: 15591591)
1. Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor.
Kiachopoulos S; Bracher A; Winklhofer KF; Tatzelt J
J Biol Chem; 2005 Mar; 280(10):9320-9. PubMed ID: 15591591
[TBL] [Abstract][Full Text] [Related]
2. Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation.
Winklhofer KF; Heske J; Heller U; Reintjes A; Muranyi W; Moarefi I; Tatzelt J
J Biol Chem; 2003 Apr; 278(17):14961-70. PubMed ID: 12556465
[TBL] [Abstract][Full Text] [Related]
3. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
4. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
[TBL] [Abstract][Full Text] [Related]
5. Structural instability of the prion protein upon M205S/R mutations revealed by molecular dynamics simulations.
Hirschberger T; Stork M; Schropp B; Winklhofer KF; Tatzelt J; Tavan P
Biophys J; 2006 Jun; 90(11):3908-18. PubMed ID: 16513786
[TBL] [Abstract][Full Text] [Related]
6. Function of Prion Protein and the Family Member, Shadoo.
Onodera T; Nishimura T; Sugiura K; Sakudo A
Curr Issues Mol Biol; 2020; 36():67-88. PubMed ID: 31559969
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance.
Gauczynski S; Krasemann S; Bodemer W; Weiss S
J Cell Sci; 2002 Nov; 115(Pt 21):4025-36. PubMed ID: 12356908
[TBL] [Abstract][Full Text] [Related]
8. α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.
Kobayashi A; Hirata T; Nishikaze T; Ninomiya A; Maki Y; Takada Y; Kitamoto T; Kinoshita T
J Biol Chem; 2020 May; 295(22):7789-7798. PubMed ID: 32321762
[TBL] [Abstract][Full Text] [Related]
9. Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.
Rambold AS; Miesbauer M; Rapaport D; Bartke T; Baier M; Winklhofer KF; Tatzelt J
Mol Biol Cell; 2006 Aug; 17(8):3356-68. PubMed ID: 16707568
[TBL] [Abstract][Full Text] [Related]
10. Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.
Chen W; van der Kamp MW; Daggett V
Biochemistry; 2010 Nov; 49(45):9874-81. PubMed ID: 20949975
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
12. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
13. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
[TBL] [Abstract][Full Text] [Related]
14. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
15. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.
Hackl S; Becker CFW
J Pept Sci; 2019 Oct; 25(10):e3216. PubMed ID: 31713950
[TBL] [Abstract][Full Text] [Related]
16. The elusive intermediate on the folding pathway of the prion protein.
Jenkins DC; Sylvester ID; Pinheiro TJ
FEBS J; 2008 Mar; 275(6):1323-35. PubMed ID: 18279390
[TBL] [Abstract][Full Text] [Related]
17. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
[TBL] [Abstract][Full Text] [Related]
18. The prion protein globular domain and disease-related mutants studied by molecular dynamics simulations.
Billeter M; Wüthrich K
Arch Virol Suppl; 2000; (16):251-63. PubMed ID: 11214929
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.
Daniels M; Cereghetti GM; Brown DR
Eur J Biochem; 2001 Dec; 268(23):6155-64. PubMed ID: 11733010
[TBL] [Abstract][Full Text] [Related]
20. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
